Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
about
Medicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient SensorsTherapeutic phytogenic compounds for obesity and diabetesCentral inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat dietBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialPreparation of Ginseng Extract with Enhanced Levels of Ginsenosides Rg1 and Rb1 Using High Hydrostatic Pressure and Polysaccharide Hydrolases.Red ginseng treatment for two weeks promotes fat metabolism during exercise in mice.Weight loss herbal intervention therapy (W-LHIT) a non-appetite suppressing natural product controls weight and lowers cholesterol and glucose levels in a murine modelGinsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action.Ginsenoside Rb1 ameliorates liver fat accumulation by upregulating perilipin expression in adipose tissue of db/db obese mice.Null effect of ginsenoside Rb1 on improving glycemic status in men during a resistance training recovery.Some pharmacological effects of cinnamon and ginger herbs in obese diabetic ratsBai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in ratsThe aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic miceHigh Hydrostatic Pressure Extract of Red Ginseng Attenuates Inflammation in Rats with High-fat Diet Induced Obesity.Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats.Botanical compounds: effects on major eye diseasesGinsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue.Ginseng and diabetes: the evidences from in vitro, animal and human studies.Anti-diabetic potential of Panax notoginseng saponins (PNS): a review.Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.Protopanaxadiol and Protopanaxatriol-Type Saponins Ameliorate Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus in High-Fat Diet/Streptozocin-Induced Mice.Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications.Modulation of leptin resistance by food compounds.Dynamic Changes in Neutral and Acidic Ginsenosides with Different Cultivation Ages and Harvest Seasons: Identification of Chemical Characteristics for Panax ginseng Quality Control.Aguamiel concentrate from Agave salmiana and its extracted saponins attenuated obesity and hepatic steatosis and increased Akkermansia muciniphila in C57BL6 miceGinsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats.Effects of ginseng on stress-related depression, anxiety, and the hypothalamic-pituitary-adrenal axis.Ginsenoside Rb1 Enhances Atherosclerotic Plaque Stability by Improving Autophagy and Lipid Metabolism in Macrophage Foam Cells.Anti-obesity and hypolipidemic effects of Fuzhuan brick tea water extract in high-fat diet-induced obese rats.The anti-obesity effects of the dietary combination of fermented red ginseng with levan in high fat diet mouse model.BDNF/TrkB signaling mediates the anorectic action of estradiol in the nucleus tractus solitarius.Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway.Ginsenoside Rb1 improves leptin sensitivity in the prefrontal cortex in obese mice.Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy.Ginsenoside Rb1 exerts antidiabetic action on C2C12 muscle cells by leptin receptor signaling pathway.Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression.Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions.
P2860
Q26770832-2E5DC9AC-28F7-4503-946E-F971F413AFE1Q27004043-982F9F8D-C0D6-4C19-927A-AC4B2A11ABFCQ28541621-7E2A6117-D1BA-4ABA-A3D3-FB0351192685Q29994589-4E84D94E-39F2-4DBD-802C-A814F9FE4505Q33609170-6CB81EF6-B858-4CE6-B223-08B832571EBCQ33702736-62EA8609-D180-4305-93B0-37D914CC9814Q34017884-8E5A815E-7B3E-4346-AFFC-8CF2DECEC783Q34720246-FC8AB384-193B-4776-B848-BEDDC11C4C0AQ34881598-D96FB37C-0AD7-47F7-B0E1-3573FA1A6675Q35863097-3FDC010B-E74C-4877-8514-2C16C8A5AEF7Q35984166-58765C2B-9E64-451C-BD43-A2B8DC56E4E6Q36078113-12215DB8-5652-4587-9886-9959D6143A52Q36174315-6A952C96-C7BD-4825-BC9D-CDC1BD28098FQ36249003-472FE228-48B3-45B2-AA2E-FDF307A7EBEBQ36379486-8B79DF0A-FE22-4266-822C-8081B94F7ECCQ36429308-10212833-340E-4189-BF02-3038F0089D34Q36754833-14C5B7B6-B1FD-4D06-A139-BB4C370B3B49Q36988482-DD7C931F-CF42-465D-B665-0E6682E0DFF4Q37314354-4728B2D6-CA58-484B-9252-8E0DF55E70B3Q38110276-7C759B98-05F1-4115-A42F-FD95DE11419EQ38121039-291DE092-CE02-4717-9194-F7F5E434292CQ38283110-1C9D1A20-A6F5-4E89-BF1C-A993A5E877BCQ38639865-ED0B7089-4066-4F88-BCFB-035FE2380FD0Q38645509-74540A9D-64FA-43E8-B92B-247A0D91BE26Q38722161-ADD3EE6C-EF73-4E0C-A462-E5233ABBC0EAQ38805038-62F79422-8BD6-4B32-AEF0-A0ED8D2ECA79Q41203375-4CB7114A-497D-4FF0-A9E9-2841509ED1A3Q42085077-D7C3F1D1-38D9-4F1B-BE12-4F4F69390F5BQ42279202-C5FBFCD9-ACAD-48DC-A4B8-0944CDC5768DQ44258998-BA0C6283-5978-41EA-B00B-2C8CF20BB08FQ44568135-00F1E5B8-C156-4592-909F-8DF84CC29D61Q44571547-3F559BAD-A1B2-46F2-BCE0-6EB607A73CF4Q47094057-C3AAA4EC-84AB-4603-BFBF-A8865C2721C0Q47150206-3E336CFF-7B71-4C1E-B9D2-4FF021B95FFBQ47410499-B1E5BF13-1E75-43C2-A41A-EAA6D73420A6Q47795728-04481E88-7CD0-4FC8-AB7C-6F3B560F56D8Q50973299-167A9006-A4D7-404F-AA58-9A1344D5F27FQ52739101-B1D3A10F-DC91-44BF-8A77-5F53038C74CEQ54112971-74A0F5DA-2E1F-4791-858D-AE7D7C6F28E5
P2860
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@ast
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@en
type
label
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@ast
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@en
prefLabel
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@ast
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@en
P2093
P2860
P356
P1433
P1476
Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats
@en
P2093
Guangji Wang
Kristina J Liu
Patrick Tso
Stephen C Woods
Yuqing Xiong
P2860
P304
P356
10.2337/DB10-0315
P407
P577
2010-08-03T00:00:00Z